Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05736510
Other study ID # 2212-028-1383
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 15, 2023
Est. completion date February 23, 2024

Study information

Verified date February 2023
Source Seoul National University Hospital
Contact Jeong-Hwa Seo, MD.,PhD.
Phone +82-10-55020551
Email eongpa@empas.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will compare whether there is a significant difference in the time required for general anesthesia recovery according to application of the binaural sound after surgery.


Description:

After entering the operating room, electrocardiogram, pulse oxygen saturation, blood pressure meter, and sedline are attached to start monitoring vital signs and patient state index (PSI). propofol and the remifentanil continuous infusion device is connected as close as possible to the catheter insertion site. Anesthesia is induced with total intravenous anesthesia (4 ng/mL of Remifentanil, 4 mg/mL of propofol). Rocuronium is administered after checking the patient's unconsciousness. When appropriate neuromuscular blocking is reached, tracheal intubation is performed. The anesthesia maintenance is performed to keep stable vital sign and PSI between 25 and 50. End-tidal carbon dioxide is controlled to be between 30 mmHg and 40 mmHg. When the pneumoperitoneum ends, the propofol concentration is recorded (T0). The anesthesiologist in charge of anesthesia puts headphones on the patient and plays the allocated file. The allocated file is named the screening number. Depending on the allocated group, the audio file is binaural sound for the experimental group, and a silent file for the control group. The anesthesiologist cannot know group allocation, since the length and size of files are the same. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and record the time (T1). At the same time, the investigators reverse neuromuscular blocking using sugammadex (2mg/ kg). When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation. Record the time (T2) when the PSI reaches 50, the time when the patient opens eyes (T3), and the time (T4) when the extubation of endotracheal tube was done. T3-T1 is the time it took the patient to open his eyes (primary end point). Write the effect site concentration of propofol and remifentanil recorded for each time points. The patient's sedline EEG data from the end of pneumoperitoneum until the patient's exit operating room is collected as raw data. The patient's blood pressure and heart rate are measured at each time points. The investigators evaluate sedation and agitation of the patients using Ramsay Sedation Scale. In the post-anesthesia care unit, pain score (NRS 0-10), postoperative nausea vomiting, medication, and length of stay are investigated.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 106
Est. completion date February 23, 2024
Est. primary completion date November 15, 2023
Accepts healthy volunteers No
Gender Female
Age group 19 Years to 50 Years
Eligibility Inclusion Criteria: - Patients between 19 and 50 years of age who are scheduled to undergo laparoscopic salpingo-oophorectomy/ ovarian cystectomy - Intellectual level to understand the procedures of the clinical trial - Physical status classification of the American Society of Anesthesiology (ASA) 1-2 grades Exclusion Criteria: - Patients with hearing loss or using hearing aids - Patients who have been given narcotic painkillers or sedative drugs within a week. - Alcohol-dependent or drug-dependent patients - Patients with drug hypersensitivity to anesthetics - Patients with arrhythmia, cardiovascular disease, impaired heart function, decreased circulatory blood flow - Patients with liver failure - Patients with other major medical or psychological disorder that will affect the treatment response - Patients with claustrophobia or anxiety disorder - Patients with organic brain disorders or other conditions that cannot be properly measured by PSI - Patients who have been newly diagnosed with myocardial infarction, cerebral ischemic seizure, stroke, clinically significant coronary artery disease, or have undergone percutaneous carotid coronary dilatation or coronary bypass treatment within 6 months - Patients with a history of epilepsy or seizures - Patients with acute angle glaucoma - Patients who deemed unsuitable for this clinical trial

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Binaural sound
When the pneumoperitoneum ends, the anesthesiologist puts headphones on the patient and plays the allocated file. In the experimental group, the allocated file is binaural sound with 40Hz beat. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and, we reverse neuromuscular blocking using sugammadex (2mg/ kg). When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.
Control
When the pneumoperitoneum ends, the anesthesiologist puts headphones on the patient and plays the allocated file. In the control group, the allocated file is silent. Thereafter, the target of PSI is to be between 40 and 50. If the Psi increases above 50, increase the propofol concentration by 0.5 mg/mL and record it. Train of four counts keep between 1 to 3 (moderate block). When the operation is ended, stop anesthetics administration, and, we reverse neuromuscular blocking using sugammadex (2mg/ kg). When the anesthesiologist starts waking the patient up, call the patient's name (unify into "OOO, open your eyes."). The anesthesiologist lightly tap the patient's shoulder and avoid excessive sound or stimulation.

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

References & Publications (2)

Ozkose Z, Yalcin Cok O, Tuncer B, Tufekcioglu S, Yardim S. Comparison of hemodynamics, recovery profile, and early postoperative pain control and costs of remifentanil versus alfentanil-based total intravenous anesthesia (TIVA). J Clin Anesth. 2002 May;14(3):161-8. doi: 10.1016/s0952-8180(01)00368-3. — View Citation

Schmid W, Marhofer P, Opfermann P, Zadrazil M, Kimberger O, Triffterer L, Marhofer D, Klug W. Brainwave entrainment to minimise sedative drug doses in paediatric surgery: a randomised controlled trial. Br J Anaesth. 2020 Sep;125(3):330-335. doi: 10.1016/j.bja.2020.05.050. Epub 2020 Jul 8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Eye opening time The time it takes to open patient's eyes in response to the voice after the anesthetic infusion is terminated. after the anesthetic infusion is terminated until 1 hour
Secondary Extubation time The time it takes from the end of the anesthetic infusion to the extubation of endotracheal tube after the anesthetic infusion is terminated until 1 hour
Secondary Systolic blood pressure Noninvasive systolic blood pressure from the end of the anesthetic infusion to the exit of operating room until 1 hour
Secondary Diastolic blood pressure Noninvasive diastolic blood pressure from the end of the anesthetic infusion to the exit of operating room until 1 hour
Secondary Mean blood pressure Noninvasive mean blood pressure from the end of the anesthetic infusion to the exit of operating room until 1 hour
Secondary Heart rate Heart rate from the end of the anesthetic infusion to the exit of operating room until 1 hour
Secondary alpha band activity alpha band activity of electroencephalogram from Sedline data from the end of the anesthetic infusion to the exit of operating room until 1 hour
Secondary beta band activity beta band activity of electroencephalogram from Sedline data from the end of the anesthetic infusion to the exit of operating room until 1 hour
Secondary theta band activity theta band activity of electroencephalogram from Sedline data from the end of the anesthetic infusion to the exit of operating room until 1 hour
Secondary delta band activity delta band activity of electroencephalogram from Sedline data from the end of the anesthetic infusion to the exit of operating room until 1 hour
Secondary Ramsay Sedation Scale The degree of patient's sedation or agitation (1 to 6: 1 means "Patient is anxious and agitated or restless, or both"; 6 means "Patient exhibits no response") When the end of anesthesia within 5minutes
Secondary Postoperative recovery score Postoperative recovery score (0-10; activity (0-2), respiration (0-2), circulation (0-2), consciousness level (0-2), and color (0-2); optimum score 10) When the patient stay in post-anesthesia care unit up to 1 hour
Secondary Pain score Postoperative pain score using numeric rating scale(0-10: 0, no pain; 10, worst possible pain) When the patient stay in post-anesthesia care unit up to 1 hour
Secondary Rate of postoperative nausea and vomiting Rate of postoperative nausea and vomiting When the patient stay in post-anesthesia care unit up to 1 hour
Secondary Length of stay in post-anesthesia care unit Length of stay in post-anesthesia care unit From entering to exit the post-anesthesia care unit up to 2 hours
Secondary Medication Rate of administration of any medication in post-anesthesia care unit When the patient stay in post-anesthesia care unit up to 1 hour
See also
  Status Clinical Trial Phase
Recruiting NCT06063798 - Respiratory Effects of Flow-Controlled Ventilation and Jet Ventilation in Patients Undergoing Laryngotracheal Surgery N/A
Not yet recruiting NCT05035069 - Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR Phase 4
Completed NCT03861364 - Hemodynamics During Induction of General Anesthesia With High and Low Propofol Dose. Phase 4
Completed NCT02711280 - The Effect of Anesthetics on Oxidative Stress and Apoptosis Status in Children N/A
Completed NCT01199471 - Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane N/A
Completed NCT00917033 - Tracheal Intubation of Morbidly Obese Patients. GlideScope Versus Direct Laryngoscopy Phase 4
Completed NCT00391885 - Target-controlled Infusion of Propofol and Remifentanil During General Anaesthesia Guided by Entropy Phase 4
Completed NCT00552617 - A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971) Phase 2
Completed NCT03705026 - Relationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han Population
Completed NCT00552929 - A Bridging Trial Comparing Sugammadex (Org 25969) at 1-2 Post-Tetanic Count (PTC) in Caucasian Participants. Part B (P05974) Phase 2
Completed NCT00475215 - Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017) Phase 3
Completed NCT00298831 - Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023) Phase 3
Recruiting NCT03943745 - EEG Changes During Induction of Propofol Anesthesia
Completed NCT03697642 - Nasopharyngeal Airway Guide Nasogastric Tube Placement N/A
Completed NCT04595591 - Observation of Propofol Titration at Different Speeds N/A
Not yet recruiting NCT05841316 - The ED95 Dose of Sugammadex to Reverse Rocuronium-Induced Deep Neuromuscular Block Back to Shallow Neuromuscular Block
Completed NCT04532502 - Impact of Anesthetic Environment the Sex Ratio of the Children of Female Assistants
Completed NCT03330236 - EEG - Guided Anesthetic Care and Postoperative Delirium N/A
Recruiting NCT06205212 - High-flow Nasal Oxygenation During Preoxygenation and Atelectasis N/A
Completed NCT00379613 - Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(P05942) Phase 2